Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising advancements throughout various healthcare and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, extra reliable substitute for therapeutic use, part